Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
Furiex Pharmaceuticals, Inc. (FURX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2011 BW Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million
08/12/2011 BW Furiex Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
07/05/2011 BW Furiex Pharmaceuticals Announces Second Quarter 2011 Earnings Release and Conference Call
04/28/2011 BW Furiex Reports First Quarter 2011 Financial Results
04/19/2011 BW Furiex Acquires Full Exclusive License Rights to Develop and Commercialize JNJ-Q2 (fluoroquinolone)
04/04/2011 BW Furiex Pharmaceuticals Announces First Quarter 2011 Earnings Release and Conference Call
02/25/2011 BW Furiex Confirms Takeda Receives Approval of Additional NESINA® Combination Therapies with Sulfonylurea and Biguanide for Type 2 Diabetes in Japan
02/21/2011 BW Furiex Reports Fourth Quarter 2010 Financial Results
12/10/2010 BW Dr. Steve Kaldor Joins Furiex Board of Directors
11/10/2010 BW Furiex Reports Third Quarter 2010 Financial Results
10/05/2010 BW Furiex Pharmaceuticals Announces Third Quarter 2010 Earnings Release, Webcast and Conference Call

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy